Keywords: merck, co/s-p, enter, new, ldl, drug, accord

Merck & Co/S-P enter new LDL drug accord

Article | 02 April 2007

Print This

Merck & Co has signed an agreement to commence development of a combination product of its drug ezetimibe together with Pfizer's ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in